《睡眠專業人士雜誌》
星期四, 七月 23, 2026
Olympus announced the market availability of its FDA-approved Spiration Valve System (SVS) for the treatment of severe emphysema, a progressive form of Chronic Obstructive Pulmonary Disease (COPD). Prominent guidelines1,2, now recommend minimally invasive bronchoscopic lung volume reduction using endobronchial valves as an alternative treatment option for severe emphysema to more […]
The FDA has approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). Mylan obtained approval to […]
Teva Pharmaceutical Industries Ltd. announced that the FDA has approved ProAir® Digihaler™ (albuterol sulfate 117 mcg) inhalation powder, the first and only digital inhaler with built-in sensors which connects to a companion mobile application and provides inhaler use information to people with asthma and COPD. ProAir® Digihaler™ is indicated for the treatment […]
Do you OR a friend or family member have Chronic Obstructive Pulmonary Disorder (COPD) and Obstructive Sleep Apnea (OSA)? If you answered ‘yes’ to the question above, we need your help! The COPD Foundation and American Sleep Apnea Association are working together to help patients make better use of their therapies, overcome […]
Royal Philips has launched a global initiative to celebrate everyday wins by patients, providers and caretakers regarding the management of chronic obstructive pulmonary disease (COPD). Launching on World COPD Day on 十一月 21, this awareness and celebratory campaign aims to help inspire COPD patients and their caregivers around ways to improve their overall […]
As part of COPD Awareness Month, the COPD Foundation is excited to announce the launch of the COPD Pocket Consultant Guide (PCG) app for healthcare providers. The app, designed to support the treatment and management of COPD, is now available for both iOS and Android. To download the new COPD […]
Royal Philips has announced the US launch of InnoSpire Go, Philips smallest and lightest portable hand-held nebulizer system designed to deliver medication in just four minutes, reducing treatment time by up to 25 percent. [1] The easy-to-use and virtually silent InnoSpire Go puts hospital-grade nebulizer technology into the hands of […]
Aptar Pharma has just launched PureHale, a new portable, ready-to-use drug delivery solution designed for upper respiratory care. PureHale when used in combination with saline or other natural ingredient formulations – helps relieve the symptoms of upper respiratory system conditions. PureHale will be officially launched at CPhI Worldwide in Madrid on […]
New research from Propeller Health, a digital therapeutics company, suggests that clinical guidelines for assessing asthma control may need to be updated to reflect objective patient information obtained from digital medicines. Propeller’s digital medicine platform helps patients manage diseases like asthma and COPD by delivering concrete insights on symptoms, triggers, […]
A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Albuminuria, Lung Function Decline, and Risk of Incident COPD: the NHLBI […]
